Maintaining and Growing your Presbyopic Patient Base

Show Description +

Jennifer Loh, MD, sees a topical presbyopia therapy as an exciting treatment opportunity for 40-to-50-year-old patients and who might not be ready for surgery. Dr. Loh discusses why she sees this potential non-surgical option as an opportunity to maintain and grow her patient base.

Posted: 11/23/2021

Maintaining and Growing your Presbyopic Patient Base

Jennifer Loh, MD, sees a topical presbyopia therapy as an exciting treatment opportunity for 40-to-50-year-old patients and who might not be ready for surgery. Dr. Loh discusses why she sees this potential non-surgical option as an opportunity to maintain and grow her patient base.

Posted: 11/23/2021

About Orasis Pharmaceuticals

ORASIS (OR-uh-sis) Pharmaceuticals is an emerging ophthalmic pharmaceutical company, with offices in the US and Israel, focused on developing an innovative solution for the treatment of presbyopia symptoms. Orasis’ novel proprietary formulation of low dose pilocarpine and a proprietary vehicle was purposefully designed with the patient in mind to achieve an optimal balance among efficacy, safety, and comfort.

The name Orasis has its roots in the Greek language, where it carries a literal translation of “good vision or sight.” Beyond this, however, as good vision in its positive mental/philosophical meaning — and this speaks to our aspiration as a company to develop pharmaceutical drugs that improve vision and quality of life for millions of people around the world.

Visit us online: orasis-pharma.com

Contact Us

Follow Orasis Pharmaceuticals